BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33235745)

  • 1. A case series of a mother and two daughters with a
    Elward C; Berg J; Oberlin JM; Rohena L
    Clin Case Rep; 2020 Nov; 8(11):2138-2144. PubMed ID: 33235745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncating and zinc-finger variants in GLI2 are associated with hypopituitarism.
    Corder ML; Berland S; Førsvoll JA; Banerjee I; Murray P; Bratland E; Gokhale D; Houge G; Douzgou S
    Am J Med Genet A; 2022 Apr; 188(4):1065-1074. PubMed ID: 34921505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of GLI2 in hypopituitarism phenotype.
    Arnhold IJ; França MM; Carvalho LR; Mendonca BB; Jorge AA
    J Mol Endocrinol; 2015 Jun; 54(3):R141-50. PubMed ID: 25878059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel truncating variant of GLI2 associated with Culler-Jones syndrome impairs Hedgehog signalling.
    Valenza F; Cittaro D; Stupka E; Biancolini D; Patricelli MG; Bonanomi D; Lazarević D
    PLoS One; 2019; 14(1):e0210097. PubMed ID: 30629636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Holoprosencephaly in a family segregating novel variants in ZIC2 and GLI2.
    Wannasilp N; Solomon BD; Warren-Mora N; Clegg NJ; Delgado MR; Lacbawan F; Hu P; Winder TL; Roessler E; Muenke M
    Am J Med Genet A; 2011 Apr; 155A(4):860-4. PubMed ID: 21416594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with a mild holoprosencephaly spectrum phenotype and heterotaxy and a 1.3 Mb deletion encompassing GLI2.
    Kevelam SH; van Harssel JJ; van der Zwaag B; Smeets HJ; Paulussen AD; Lichtenbelt KD
    Am J Med Genet A; 2012 Jan; 158A(1):166-73. PubMed ID: 22106008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: A case of Culler-Jones syndrome caused by a novel mutation of
    Zhang Y; Dong B; Xue Y; Wang Y; Yan J; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1133492. PubMed ID: 36936162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly.
    França MM; Jorge AA; Carvalho LR; Costalonga EF; Vasques GA; Leite CC; Mendonca BB; Arnhold IJ
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E384-91. PubMed ID: 20685856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A familial GLI2 deletion (2q14.2) not associated with the holoprosencephaly syndrome phenotype.
    Kordaß U; Schröder C; Elbracht M; Soellner L; Eggermann T
    Am J Med Genet A; 2015 May; 167A(5):1121-4. PubMed ID: 25820550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly.
    Bear KA; Solomon BD; Antonini S; Arnhold IJ; França MM; Gerkes EH; Grange DK; Hadley DW; Jääskeläinen J; Paulo SS; Rump P; Stratakis CA; Thompson EM; Willis M; Winder TL; Jorge AA; Roessler E; Muenke M
    J Med Genet; 2014 Jun; 51(6):413-8. PubMed ID: 24744436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relatively high frequency of non-synonymous GLI2 variants in patients with congenital hypopituitarism without holoprosencephaly.
    França MM; Jorge AA; Carvalho LR; Costalonga EF; Otto AP; Correa FA; Mendonca BB; Arnhold IJ
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):551-7. PubMed ID: 22967285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of a heterozygous GLI2 missense mutation in patients with multiple pituitary hormone deficiency.
    Flemming GM; Klammt J; Ambler G; Bao Y; Blum WF; Cowell C; Donaghue K; Howard N; Kumar A; Sanchez J; Stobbe H; Pfäffle RW
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E567-75. PubMed ID: 23408573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel GLI2 mutation responsible for congenital hypopituitarism and polymalformation syndrome.
    Martín-Rivada Á; Rodríguez-Contreras FJ; Muñoz-Calvo MT; Güemes M; González-Casado I; Del Pozo JS; Campos-Barros Á; Argente J
    Growth Horm IGF Res; 2019 Feb; 44():17-19. PubMed ID: 30583238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the sonic hedgehog signalling pathway in patients with midline defects and congenital hypopituitarism.
    Gregory LC; Gaston-Massuet C; Andoniadou CL; Carreno G; Webb EA; Kelberman D; McCabe MJ; Panagiotakopoulos L; Saldanha JW; Spoudeas HA; Torpiano J; Rossi M; Raine J; Canham N; Martinez-Barbera JP; Dattani MT
    Clin Endocrinol (Oxf); 2015 May; 82(5):728-38. PubMed ID: 25327282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
    Kingdom R; Wright CF
    Front Genet; 2022; 13():920390. PubMed ID: 35983412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete penetrance, variable expressivity, or dosage insensitivity in four families with directly transmitted unbalanced chromosome abnormalities.
    Bateman MS; Collinson MN; Bunyan DJ; Collins AL; Duncan P; Firth R; Harrison V; Homfray T; Huang S; Kirk B; Lachlan KL; Maloney VK; Barber JCK
    Am J Med Genet A; 2018 Feb; 176(2):319-329. PubMed ID: 29194955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique near-complete deletion of GLI2 in a patient with combined pituitary hormone deficiency and post-axial polydactyly.
    Elizabeth MSM; Verkerk AJMH; Hokken-Koelega ACS; Verlouw JAM; Argente J; Pfaeffle R; Visser TJ; Peeters RP; De Graaff LCG
    Growth Horm IGF Res; 2020 Feb; 50():35-41. PubMed ID: 31862539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death.
    Coll M; Pérez-Serra A; Mates J; Del Olmo B; Puigmulé M; Fernandez-Falgueras A; Iglesias A; Picó F; Lopez L; Brugada R; Campuzano O
    Biology (Basel); 2017 Dec; 7(1):. PubMed ID: 29278359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonic Hedgehog mutations are not a common cause of congenital hypopituitarism in the absence of complex midline cerebral defects.
    Paulo SS; Fernandes-Rosa FL; Turatti W; Coeli-Lacchini FB; Martinelli CE; Nakiri GS; Moreira AC; Santos AC; de Castro M; Antonini SR
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):562-9. PubMed ID: 25056824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial microtia in four generations with variable expressivity and incomplete penetrance in association with type I syndactyly.
    Balci S; Boduroğlu K; Kaya S
    Turk J Pediatr; 2001; 43(4):362-5. PubMed ID: 11765172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.